Here's what I am seeing today: speculative buying based on the webinar announcement for a potential pump and dump going into Thursday.
Only thing that will change the SP med-long term is a collab with $ upfront or milestone payments involved.
So worst case scenario is that the HSV-2 Vax is a bomb. Right? In that case, we'd - I hope - see AHZ divest itself of the Immunotherapies division immediately making the company CF+ by a large margin in the next 6 months easy.
If not a bomb then we'd have to see a partnership/collab with the aforementioned up fronts/milestone to justify keep running it.
So we need decisive action on this now. If a CR is proffered to fund the operational costs of the Vax program I will be very very disappointed.
- Forums
- ASX - By Stock
- AVR
- Ann: HSV-2 Phase IIa Results Investor Webinar
Ann: HSV-2 Phase IIa Results Investor Webinar, page-128
-
- There are more pages in this discussion • 169 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M |
Open | High | Low | Value | Volume |
$10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $9.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.99 | 1999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 9.600 |
1 | 1050 | 9.500 |
1 | 1050 | 9.400 |
2 | 1060 | 9.350 |
2 | 585 | 9.300 |
Price($) | Vol. | No. |
---|---|---|
10.000 | 493 | 1 |
10.300 | 1000 | 1 |
10.450 | 357 | 1 |
10.900 | 1500 | 1 |
11.000 | 13000 | 2 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |